Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 9/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | METAP2 | P50579 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17691665 | 0.91 | KDM4E (0.38) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL17759699 | 0.90 | KDM4E (0.37) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL15583025 | 0.90 | KDM4E (0.37) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL17759387 | 0.90 | KDM4E (0.37) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19653630 | 0.89 | KDM4E (0.36) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19653563 | 0.89 | KDM4E (0.36) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19653648 | 0.89 | KDM4E (0.35) | PDK2KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL18268528 | 0.88 | PDK2 (0.35) | PDK2GRM5NPY5RMAPK14 | |
| SCHEMBL15338026 | 0.88 | KDM4E (0.40) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL19653533 | 0.87 | KDM4E (0.38) | PDK2KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222160-A1 | ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME | ALDH1A2, LAGE3, AOX1 | PDK2 1387/4885HTR1A 1902/4885HTR7 3601/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.